glp-1 side effect class action in michigan constipation glp-1 diarrhea class action in michigan Adverse effects of GLP-1 class drugs. Gastrointestinal issues GLP-1 medications, commonly used for

BPC-157: A Prohibited Peptide and an Unapproved Drug

Initiation of therapy may be prompted by trough (pre-dialysis) plasma levocarnitine concentrations that are below normal (40 to 50 mol/L)

Nanoparticles and danger signals: oral delivery vehicles as potential disruptors of intestinal barrier homeostasis

Whether youre in Jacksonville or joining us via telemedicine from elsewhere in FL, GA, AL, VA, NC, or SC, were ready to help you achieve lasting weight loss results

As of mid-2025, approximately 1012 million Americans are actively filling GLP-1 prescriptions for weight management or diabetes treatment, according to IQVIA patient data with Gallup and RAND surveys suggesting as many as 1112% of US adults report current or recent use

GLP-1s are not meant for a short-term or cosmetic weight loss